The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

This study was designed to determine the effects of vandetanib, a small-molecule receptor tyrosine kinase inhibitor of vascular endothelial growth factor and epidermal growth factor receptor, on paclitaxel (PTX) tumor distribution and antitumor activity in xenograft models of human ovarian carcinoma...

Full description

Bibliographic Details
Main Authors:	Cesca, M, Frapolli, R, Berndt, A, Scarlato, V, Richter, P, Kosmehl, H, D'Incalci, M, Ryan, A, Giavazzi, R
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
by: Wachsberger, P, et al.
Published: (2009)

Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS.
by: Cohen-Jonathan, E, et al.
Published: (2000)

A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel.
by: Zhou, J, et al.
Published: (2016)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.
by: Tai, J, et al.
Published: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat
by: Tai, J, et al.
Published: (2010)

Assessment Of Antitumor Activity Of Standardized Polyalthia Longifolia Leaf Extract In Hela Cell Tumor Xenograft Mouse Model
by: Braganza, Cilwyn Shalitha
Published: (2022)

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
by: Cervellini, I, et al.
Published: (2010)

Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
by: Choi, S, et al.
Published: (2008)

Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).
by: Siemann, D, et al.
Published: (2009)

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
by: Kumar, K, et al.
Published: (2013)

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts.
by: Kumar, K, et al.
Published: (2013)

First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence
by: Sandercock, J, et al.
Published: (1998)

CELL-MEDIATED RESPONSES TO TUMOR XENOGRAFTS IN MICE
by: Simpson, E, et al.
Published: (1972)

iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe.
by: Jiang, L, et al.
Published: (2011)

The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel.
by: Ahmed, A, et al.
Published: (2007)

Controlled release of paclitaxel from a self-assembling peptide hydrogel formed in situ and antitumor study in vitro
by: Liu, Jingping, et al.
Published: (2014)

Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model
by: Wood, Joseph, et al.
Published: (2016)

Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma.
by: Medinger, M, et al.
Published: (2009)

Lymphocyte-dependent antibody in a tumor xenograft system.
by: Simpson, E, et al.
Published: (1973)

Targeted Therapy Against All Three VEGF Receptors by Cediranib Enhances the Antitumor and Anti-metastatic Effects of Paclitaxel and Radiation in an Orthotopic Human Lung Cancer Model
by: Takahashi, O, et al.
Published: (2010)

Biophysical and computational characterization of vandetanib–lysozyme interaction
by: Kabir, Md Zahirul, et al.
Published: (2018)

The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
by: Le, X, et al.
Published: (2011)

In vitro effects of vandetanib on VEGFR2, EGFR and RET phosphorylation, endothelial cell tube formation, and tumor cell growth and survival
by: Brave, SR, et al.
Published: (2007)

Integrated genomic analyses of ovarian carcinoma
by: Meyerson, Matthew L., et al.
Published: (2012)

Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP.
by: Xie, X, et al.
Published: (2013)

Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer.
by: Zweifel, M, et al.
Published: (2011)

Antitumor effect of the vascular-disrupting agent ZD6126 in a murine renal cell carcinoma model.
by: Medinger, M, et al.
Published: (2011)

Targeting gene therapy to intraperitoneal ovarian carcinoma
by: Morrison, J
Published: (2006)

Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenografts.
by: Costantini, D, et al.
Published: (2010)

Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
by: Alferez, D, et al.
Published: (2010)

Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
by: Heymach, J, et al.
Published: (2008)

Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma.
by: Liu, W, et al.
Published: (2009)

Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models.
by: Blakey, D, et al.
Published: (2002)

Differential microrna expression in primary peritoneal serous carcinoma versus ovarian serous carcinoma
by: O'Leary, J, et al.
Published: (2008)

Paclitaxel sensitivity of ovarian cancer can be enhanced by knocking down pairs of kinases that regulate MAP4 phosphorylation and microtubule stability
by: Yang, H, et al.
Published: (2018)

Activation of human dendritic cells for immunotherapy in ovarian carcinoma
by: Brencicova, E, et al.
Published: (2012)

The injury response to DNA damage in live tumor cells promotes antitumor immunity
by: Sriram, Ganapathy, et al.
Published: (2023)

Improved therapeutic antibody delivery to xenograft tumors using cavitation nucleated by gas-entrapping nanoparticles
by: Grundy, M, et al.
Published: (2021)

Effect of AMH on primordial follicle populations in mouse ovaries and human pre-pubertal ovarian xenografts during doxorubicin treatment
by: Wei, X, et al.
Published: (2024)

Evaluation of retinal nerve fibre layer and macular thickness pre-and post-chemotherapy with carboplatin and paclitaxel in patients with endometrial and ovarian cancer
by: Juen, Chin Ju
Published: (2021)